The intraurethral catheter--three years of experience.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 7689972.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Ninety-four patients with benign prostatic hyperplasia who had anesthetic contraindications to surgery were treated by insertion of 130 intraurethral catheters (IUC). Of the 130 IUCs inserted, 80.8% were successful and in 19.2% the IUC had to be removed earlier than intended: improper placement, displacement of the stent and residual urine were the main reasons for failure. All patients with a successfully inserted IUC were continent. Fifty-three IUCs were left for 1-6 months and 52 stents remained in place for over 6 up to 19 months. Bacteriuria was found in 13% of the patients with IUCs, but only 2.4% of the patients had clinical urinary tract infection. The IUC may be used as an alternative to surgery in high risk patients and as an alternative to an indwelling catheter.
Medical subject headings
- Prostatic Hyperplasia
- Urinary Catheterization